Cargando…

Design and molecular dynamic simulation of a new double-epitope tolerogenic protein as a potential vaccine for multiple sclerosis disease

One of the debilitating diseases affecting the central nervous system is multiple sclerosis (MS). As there is no definitive treatment for MS, researchers have mainly consented with optimization of strategies which slows down the progression of the disease such as specific auto-antigens tolerance ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banisharif-Dehkordi, Fatemeh, Mobini-Dehkordi, Mohsen, Shakhsi-Niaei, Mostafa, Mahnam, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407332/ https://www.ncbi.nlm.nih.gov/pubmed/30936929 http://dx.doi.org/10.4103/1735-5362.251849

Ejemplares similares

Computational comparison of two new fusion proteins for multiple sclerosis
por: Payab, Nasrin, et al.
Publicado: (2018)

Y-chromosomal Status of Six Indo-European-speaking Arab Subpopulations in Chaharmahal and Bakhtiari Province, Iran
por: BANIMEHDI-DEHKORDI, Elham, et al.
Publicado: (2018)

Design of a novel metal binding peptide by molecular dynamics simulation to sequester Cu and Zn ions
por: Mahnam, K., et al.
Publicado: (2014)

In silico design of a multi-epitope vaccine against HPV16/18
por: Sanami, Samira, et al.
Publicado: (2022)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2
por: Shakhsi-Niaei, Mostafa, et al.
Publicado: (2021)

Response Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
por: Shakhsi-Niaei, Mostafa, et al.
Publicado: (2022)

Addendum: Amplification, Sequencing and Cloning of Iranian Native Bacillus subtilis Alpha-amylase Gene in Saccharomyces cerevisiae [published in Jundishapur J Microbiol. 2013;6(8):e7371]
por: Afzal-Javan, Fahimeh, et al.
Publicado: (2014)

Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015)

Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis
por: Hassanpour-Dehkordi, Ali, et al.
Publicado: (2014)

Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study
por: Sanami, Samira, et al.
Publicado: (2021)

Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches
por: Sanami, Samira, et al.
Publicado: (2021)

Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”
por: Behdarvand Dehkordi, Fereshteh, et al.
Publicado: (2023)

Effect of dynamic neuromuscular stabilization on balance and trunk function in people with multiple sclerosis: protocol for a randomized control trial
por: Abadi Marand, Laleh, et al.
Publicado: (2022)

Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach
por: Sanami, Samira, et al.
Publicado: (2020)

Studying the interaction between the new neodymium (Nd) complex with the ligand of 1,10-phenanthroline with FS-DNA and BSA
por: Raeisi Vanani, Ahmad, et al.
Publicado: (2023)

Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach
por: Alizadeh, Morteza, et al.
Publicado: (2022)

Multiple Sclerosis and the LIF/IL-6 Axis: Use of Nanotechnology to Harness the Tolerogenic and Reparative Properties of LIF
por: Metcalfe, Su M., et al.
Publicado: (2015)

Spectroscopic and molecular modeling studies of binding interaction between the new complex of yttrium and 1,10-phenanthroline derivatives with DNA and BSA
por: Khorshidi, Mahsa, et al.
Publicado: (2023)

The functional mechanisms of synchronizing royal jelly consumption and physical activity on rat with multiple sclerosis-like behaviors hallmarks based on bioinformatics analysis, and experimental survey
por: Lohrasbi, Maryam, et al.
Publicado: (2022)

Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies
por: Nourian Dehkordi, Azar, et al.
Publicado: (2019)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein–Barr Virus Infection
por: ‘t Hart, Bert A.
Publicado: (2020)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2021)

In silico screening and molecular dynamics simulations toward new human papillomavirus 16 type inhibitors
por: Razzaghi-Asl, Nima, et al.
Publicado: (2022)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

Identification of Candidate Tolerogenic CD8(+) T Cell Epitopes for Therapy of Type 1 Diabetes in the NOD Mouse Model
por: Yu, Cailin, et al.
Publicado: (2016)

MicroRNA-372 acts as a double-edged sword in human cancers
por: Tajik, Fatemeh, et al.
Publicado: (2023)

Immunoinformatic prediction of potential immunodominant epitopes from cagW in order to investigate protection against Helicobacter pylori infection based on experimental consequences
por: Chehelgerdi, Matin, et al.
Publicado: (2023)

Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis
por: Kleist, Christian, et al.
Publicado: (2016)

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
por: Zubizarreta, Irati, et al.
Publicado: (2019)

Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H(2)S-Producing Enzymes in Multiple Sclerosis
por: Lazarević, Milica, et al.
Publicado: (2020)

Efficacy of Personalized-Computerized Inhibitory Training program (PCIT) combined with exposure and response prevention on treatment outcomes in patients with contamination obsessive–compulsive disorder
por: Dehkordi, Fatemeh Jafarian, et al.
Publicado: (2023)

Molecular Dynamics and Docking Investigations of Several Zoanthamine-Type Marine Alkaloids as Matrix Metaloproteinase-1 Inhibitors
por: Farrokhnia, Maryam, et al.
Publicado: (2017)

Tolerogenic citrullinated peptide for arthritis
por: Gertel, Smadar, et al.
Publicado: (2015)

In Silico Perspectives on the Prediction of the PLP’s Epitopes involved in Multiple Sclerosis
por: Zamanzadeh, Zahra, et al.
Publicado: (2017)

Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials
por: Flórez-Grau, Georgina, et al.
Publicado: (2018)

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2023)

Comparing the Effect of Intranasal Lidocaine 4% with Peppermint Essential Oil Drop 1.5% on Migraine Attacks: A Double-Blind Clinical Trial
por: Rafieian-kopaei, Mahmood, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hivjma8o52fdsd7v9lg7qqvelj